These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28904884)

  • 1. Circulating tumor cells and CDX models as a tool for preclinical drug development.
    Lallo A; Schenk MW; Frese KK; Blackhall F; Dive C
    Transl Lung Cancer Res; 2017 Aug; 6(4):397-408. PubMed ID: 28904884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses.
    Suvilesh KN; Nussbaum YI; Radhakrishnan V; Manjunath Y; Avella DM; Staveley-O'Carroll KF; Kimchi ET; Chaudhuri AA; Shyu CR; Li G; Pantel K; Warren WC; Mitchem JB; Kaifi JT
    Mol Cancer; 2022 Mar; 21(1):73. PubMed ID: 35279152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.
    Morrow CJ; Trapani F; Metcalf RL; Bertolini G; Hodgkinson CL; Khandelwal G; Kelly P; Galvin M; Carter L; Simpson KL; Williamson S; Wirth C; Simms N; Frankliln L; Frese KK; Rothwell DG; Nonaka D; Miller CJ; Brady G; Blackhall FH; Dive C
    Ann Oncol; 2016 Jun; 27(6):1155-1160. PubMed ID: 27013395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explants.
    Vickers AJ; Frese K; Galvin M; Carter M; Franklin L; Morris K; Pierce J; Descamps T; Blackhall F; Dive C; Carter L
    Lung Cancer; 2020 Dec; 150():216-220. PubMed ID: 33221678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies.
    Pawlikowska P; Faugeroux V; Oulhen M; Aberlenc A; Tayoun T; Pailler E; Farace F
    J Thorac Dis; 2019 Jan; 11(Suppl 1):S45-S56. PubMed ID: 30775027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts.
    Drapkin BJ; George J; Christensen CL; Mino-Kenudson M; Dries R; Sundaresan T; Phat S; Myers DT; Zhong J; Igo P; Hazar-Rethinam MH; Licausi JA; Gomez-Caraballo M; Kem M; Jani KN; Azimi R; Abedpour N; Menon R; Lakis S; Heist RS; Büttner R; Haas S; Sequist LV; Shaw AT; Wong KK; Hata AN; Toner M; Maheswaran S; Haber DA; Peifer M; Dyson N; Thomas RK; Farago AF
    Cancer Discov; 2018 May; 8(5):600-615. PubMed ID: 29483136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis.
    Ramirez AB; Bhat R; Sahay D; De Angelis C; Thangavel H; Hedayatpour S; Dobrolecki LE; Nardone A; Giuliano M; Nagi C; Rimawi M; Osborne CK; Lewis MT; Stilwell JL; Kaldjian EP; Schiff R; Trivedi MV
    BMC Cancer; 2019 Mar; 19(1):220. PubMed ID: 30871481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine.
    Tellez-Gabriel M; Cochonneau D; Cadé M; Jubellin C; Heymann MF; Heymann D
    Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30586936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of circulating tumor cells in lung cancer: a narrative review.
    Hamilton G; Rath B; Stickler S
    Transl Lung Cancer Res; 2023 Apr; 12(4):877-894. PubMed ID: 37197632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.
    Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS
    Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
    Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
    Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer.
    Kapeleris J; Kulasinghe A; Warkiani ME; Vela I; Kenny L; O'Byrne K; Punyadeera C
    Front Oncol; 2018; 8():311. PubMed ID: 30155443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
    Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Circulating-Tumor-Cell-Targeted Sequencing to Identify Somatic Variants in Liquid Biopsies in Non-Small-Cell Lung Cancer Patients.
    Barbirou M; Miller A; Manjunath Y; Ramirez AB; Ericson NG; Staveley-O'Carroll KF; Mitchem JB; Warren WC; Chaudhuri AA; Huang Y; Li G; Tonellato PJ; Kaifi JT
    Curr Issues Mol Biol; 2022 Feb; 44(2):750-763. PubMed ID: 35723337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
    Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
    Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
    Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
    BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models to study CTCs and CTC culture methods.
    Fernández-Santiago C; López-López R; Piñeiro R
    Int Rev Cell Mol Biol; 2023; 381():57-98. PubMed ID: 37739484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation.
    Kang HN; Choi JW; Shim HS; Kim J; Kim DJ; Lee CY; Hong MH; Park SY; Park AY; Shin EJ; Lee SY; Pyo KH; Yun MR; Choi HM; Lee SS; Kim SY; Lee H; Paik S; Cho BC; Lee JG; Kim HR
    Lung Cancer; 2018 Oct; 124():168-178. PubMed ID: 30268457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explants.
    Tayoun T; Faugeroux V; Oulhen M; Déas O; Michels J; Brulle-Soumare L; Cairo S; Scoazec JY; Marty V; Aberlenc A; Planchard D; Remon J; Ponce S; Besse B; Kannouche PL; Judde JG; Pawlikowska P; Farace F
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35511434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.